Improving decisions to reduce HIV and HCV transmission linked to drug use
Making Better Decisions: Policy Modeling for AIDS and Drug Abuse
This study looks at how the rise in drug use during the Covid pandemic is affecting the spread of HIV and hepatitis C, and it aims to find better ways to help people stay healthy by understanding the social factors that influence prevention programs.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-11013292 on NIH RePORTER |
What this research studies
This research investigates how the ongoing substance use epidemic, exacerbated by the Covid pandemic, affects the transmission of HIV and hepatitis C virus (HCV). It aims to develop new modeling methods to analyze health disparities and the social determinants that impact the delivery of prevention programs. By examining the effects of opioid and stimulant use on disease transmission, the research seeks to identify effective strategies to mitigate these harms and improve public health outcomes. Patients may benefit from interventions designed based on the findings of this research.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who use opioids or stimulants and are at risk for HIV or HCV.
Not a fit: Patients who do not engage in substance use or are not at risk for HIV or HCV may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective strategies for preventing HIV and HCV transmission among individuals affected by substance use.
How similar studies have performed: Previous research has shown success in using modeling approaches to address public health crises related to substance use and infectious diseases.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Owens, Douglas K — Stanford University
- Study coordinator: Owens, Douglas K
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.